LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
Stay updated with breaking news from Development Cloud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
PLEASANTON, Calif., Jan. 20, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that the Lymphoma Academic Research Organization (LYSARC) selected...
VEEV earnings call for the period ending September 30, 2021.
VEEV earnings call for the period ending March 31, 2021.
Veeva Development Cloud Streamlining Drug Development Industrywide Unified application suites for clinical, regulatory, quality, and safety eliminate siloes to increase efficiency and improve compliance News provided by Share this article Share this article PLEASANTON, Calif., May 19, 2021 /PRNewswire/ -- A growing number of life sciences companies are adopting Veeva Development Cloud applications from Veeva Systems (NYSE: VEEV) in an industrywide shift to streamline drug development. More than 650 companies use Veeva Development Cloud applications today, and more than 250 are leveraging mult...